Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Ligand Pharmaceuticals (LGND) over the last 12 years, with Q3 2025 value amounting to $3.9 million.

  • Ligand Pharmaceuticals' Interest & Investment Income rose 18760.21% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 1765.38%. This contributed to the annual value of $8.1 million for FY2024, which is 446.12% up from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Interest & Investment Income of $3.9 million as of Q3 2025, which was up 18760.21% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Interest & Investment Income ranged from a high of $3.9 million in Q3 2025 and a low of $134000.0 during Q1 2022
  • In the last 5 years, Ligand Pharmaceuticals' Interest & Investment Income had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • In the last 5 years, Ligand Pharmaceuticals' Interest & Investment Income tumbled by 9374.21% in 2021 and then surged by 97089.55% in 2023.
  • Ligand Pharmaceuticals' Interest & Investment Income (Quarter) stood at $188000.0 in 2021, then surged by 444.15% to $1.0 million in 2022, then soared by 65.49% to $1.7 million in 2023, then rose by 14.06% to $1.9 million in 2024, then skyrocketed by 100.62% to $3.9 million in 2025.
  • Its Interest & Investment Income stands at $3.9 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.8 million for Q1 2025.